Loomans-Kropp, Holli A.
Elsaid, Mohamed I.
Kweon, Yesung
Noonan, Anne M.
Stanich, Peter P.
Plascak, Jesse
Kalady, Matthew F.
Doubeni, Chyke A.
Paskett, Electra D.
Funding for this research was provided by:
Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Article History
Received: 31 March 2025
Accepted: 26 August 2025
First Online: 25 September 2025
Declarations
:
: Dr. Elsaid receives research funding from Genentech and AstraZeneca. Dr. Doubeni authors topics of colorectal cancer screening in UpToDate. Dr. Paskett receives research funding from Genentech, AstraZeneca, Pfizer, Merck, and Guardant Health and is a consultant for GSK and Merck. Dr. Kalady is on the Scientific Advisory Board for Activ Surgical. None of the listed disclosures listed are related to the current work.
: STROBE guidelines were adhered to during the completion of this study.
: As the data used for this study is publicly available, institutional approval was not required.